Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Rexin-G

Next Previous
X
Search
Drug Profile

Rexin-G

Alternative Names: DeltaRex-G; Retroviral Expression Vectors Bearing Inhibitory Genes; Rexin-G; Targeted nanomedicine; Tumour-targeted gene therapy vector - Epeius

Latest Information Update: 02 Oct 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Epeius Biotechnologies
  • Developer Epeius Biotechnologies Corporation
  • Class Antineoplastics; Gene therapies
  • Mechanism of Action Gene transference
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Osteosarcoma; Soft tissue sarcoma; Pancreatic cancer
  • New Molecular Entity No

Highest Development Phases

  • Marketed Solid tumours
  • Discontinued Breast cancer; Osteosarcoma; Pancreatic cancer; Soft tissue sarcoma

Most Recent Events

  • 02 Jun 2010 Efficacy and adverse event data from the phase II portion of a phase I/II trial in chemotherapy-resistant bone and soft tissue sarcoma released by Epeius Biotechnologies
  • 24 May 2010 Efficacy and adverse events data from a phase I/II trial in Pancreatic cancer released by Epeius Biotechnologies
  • 24 May 2010 Pharmacodynamics data from a phase I/II trial in Cancer released by Epeius Biotechnologies

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top